Cartherics Pty Ltd
Ian Nisbet is a seasoned executive and leader in the biotechnology and healthcare sectors, currently serving as Co-Founder and Chief Operating Officer at Cartherics Pty Ltd since June 2016. In addition, Ian holds positions as Chairman at Vivazome Therapeutics Pty Ltd, Director at Daré Bioscience Australia Pty Ltd, ACYTE Biotech Pty Ltd, and vivoPharm Pty Ltd, along with serving as CEO at Cancure Pty Ltd and Executive Director at Senz Oncology Pty Ltd. Ian's commitment to education and mentorship is evident through involvement in the University of Melbourne STEM Industry Mentoring Program. Ian's academic background includes a PhD in Biochemistry from Monash University and a BSc in Microbiology and Biochemistry from the University of Melbourne.
This person is not in any teams
Cartherics Pty Ltd
Cartherics is a biotechnology company focused on developing innovative cancer therapies. We work to create precisely-defined immunotherapy treatments to combat a variety of cancers. We take a multi-platform approach combining the best components of immune defences utilising gene editing and CAR technology – developing more precise and more accessible treatment options for patients. We are focused on solid tumours and disrupting the tumour microenvironment (TME) to make tumours accessible to immune destruction. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer. We’re developing new forms of solid cancer care treatment - helping patients fight cancer and take back control of their lives.